BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18042045)

  • 1. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
    Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
    Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
    Kazantseva A; Sepp M; Kazantseva J; Sadam H; Pruunsild P; Timmusk T; Neuman T; Palm K
    J Neurochem; 2009 May; 109(3):807-18. PubMed ID: 19245665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human SWI/SNF subunit Brm is a regulator of alternative splicing.
    Batsché E; Yaniv M; Muchardt C
    Nat Struct Mol Biol; 2006 Jan; 13(1):22-9. PubMed ID: 16341228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1.
    Ishida M; Tanaka S; Ohki M; Ohta T
    Genes Cells; 2004 May; 9(5):419-28. PubMed ID: 15147271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.
    Zhang B; Chambers KJ; Faller DV; Wang S
    Oncogene; 2007 Nov; 26(50):7153-7. PubMed ID: 17486062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity.
    Bruelle C; Bédard M; Blier S; Gauthier M; Traish AM; Vincent M
    Biochem Cell Biol; 2011 Aug; 89(4):423-33. PubMed ID: 21819346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA.
    Gañez-Zapater A; Mackowiak SD; Guo Y; Tarbier M; Jordán-Pla A; Friedländer MR; Visa N; Östlund Farrants AK
    Mol Genet Genomics; 2022 Mar; 297(2):463-484. PubMed ID: 35187582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).
    Reyes JC; Barra J; Muchardt C; Camus A; Babinet C; Yaniv M
    EMBO J; 1998 Dec; 17(23):6979-91. PubMed ID: 9843504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
    Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
    Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.